Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis
Jan Philipp Bewersdorf,
Smith Giri,
Rong Wang,
Robert T. Williams,
Martin S. Tallman,
Amer M. Zeidan,
Maximilian Stahl
Affiliations
Jan Philipp Bewersdorf
Yale University;
Smith Giri
Division of Hematology and Oncology, University of Alabama School of Medicine;
Rong Wang
Department of Chronic Disease Epidemiology, School of Public Health, Yale University;
